Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic for #amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC)

#Genmab $GMAB $JNJ

https://t.co/MleoxBPKUr